Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease

BACKGROUND: ATP13A2 holds promise as biomarker for Parkinsońs disease (PD). No study has examined how salivary ATP13A2 is related to motor features in idiopathic PD. METHODS: Salivary ATP13A2 concentration was evaluated with ELISA, and statistical correlations of ATP13A2 level with PD parameters wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Espejo, Emilio, Gavito, Ana L., Suárez, Juan, Tolosa, Eduardo, Vilas, Dolores, Aldecoa, Iban, Berenguer, Joan, Córdoba-Fernández, Antonio, Damas-Hermoso, Fátima, Rodríguez de Fonseca, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445999/
https://www.ncbi.nlm.nih.gov/pubmed/36081833
http://dx.doi.org/10.1016/j.prdoa.2022.100163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445999/
https://www.ncbi.nlm.nih.gov/pubmed/36081833
http://dx.doi.org/10.1016/j.prdoa.2022.100163

Ejemplares similares